Last reviewed · How we verify
NCT05871645
Placenta Accreta Spectrum Management: Uterine Preservation Using JSICA Technique - Retrospective Cross-Sectional Study
NA trial testing Jakarta Surgical Uterine Conservation (JSICA) Technique in Placenta Accreta in 323 participants. Completed in 28 February 2022.
31 December 2021
Quick facts
| Lead sponsor | Dr Cipto Mangunkusumo General Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 323 |
| Start date | 1 January 2015 |
| Primary completion | 31 December 2021 |
| Estimated completion | 28 February 2022 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Jakarta Surgical Uterine Conservation (JSICA) Technique
- Standard Hysterectomy
Conditions studied
- Placenta Accreta — all drugs for Placenta Accreta →
Sponsor
Dr Cipto Mangunkusumo General Hospital
Who can join
18 and older, female only, with Placenta Accreta. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to present the Jakarta Surgical Uterine Conservation (JSICA) technique and its perioperative outcomes in Placenta Accreta Spectrum patients. Participants are all patients undergoing standard hysterectomy or the Jakarta Surgical Uterine Conservation (JSICA) technique. Researchers will compare both groups to see if there are any differences in the perioperative outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05871645
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Placenta Accreta
Currently open trials in the same condition.
- NCT07283042 — Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum · recruiting
- NCT06465836 — Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef University · NA · recruiting
- NCT06185894 — Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery · NA · recruiting
- NCT06833606 — Diagnosis and Outcomes of Placental Accretism · recruiting
- NCT05922397 — Placenta Accreta Spectrum Topographic Classification · recruiting
Other Dr Cipto Mangunkusumo General Hospital trials
Trials by the same sponsor.
- NCT07074548 — Effect of Hydroxytyrosol on NLR, MLR, and SOD in Hypertensive Pregnant Women · NA · completed
- NCT07141940 — Indonesian-Language Application-Based Guided Imagery Therapy for Insomnia and Glycemic Control in Diabetic Patients · NA · completed
- NCT07422116 — Non-Inferiority Test of Mixsafe® Compared to Neopuff® in Providing Respiratory Support to Neonates · NA · completed
- NCT06929793 — Multiple Micronutrients Supplementation on Angiogenesis and Vasculogenesis Factors, and Fetal Biometry · NA · active not recruiting
- NCT07149272 — Lactate Kinetics Analysis Related to Low-Intensity Resistance Exercise · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05871645 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr Cipto Mangunkusumo General Hospital
- Last refreshed: 7 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05871645.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing